Breast Implant-Associated Tumors.
Uwe von FritschenThomas KremerLukas PrantlAlba FrickePublished in: Geburtshilfe und Frauenheilkunde (2023)
In addition to anaplastic large T-cell lymphomas (BIA-ALCL), other implant-related tumors have been described for some years. Squamous cell carcinoma (SSC) and B-cell lymphomas occurred in very rare cases. The unexplained pathogenesis as well as the unclear individual risk profile is an ongoing source of uncertainty for patients and physicians. The pathogenesis of the tumors is still largely not understood. While BIA-ALCL occurs more frequently with textured breast implants, other tumors were also observed with smooth implants and at other implant sites. Multiple potential mechanisms are discussed. It is suspected that the etiology of a chronic inflammatory response and subsequently immunostimulation is multifactorial and appears to play a key role in the malignant transformation. Since there are currently no sufficiently valid data for a specific risk assessment, this must be done with caution. This article presents the incidence, pathogenesis, as well as the level of evidence according to the current state of knowledge, and evaluates and discusses the current literature.
Keyphrases
- soft tissue
- inflammatory response
- squamous cell carcinoma
- risk assessment
- end stage renal disease
- primary care
- systematic review
- chronic kidney disease
- ejection fraction
- human health
- peritoneal dialysis
- prognostic factors
- lipopolysaccharide induced
- electronic health record
- locally advanced
- big data
- patient reported outcomes
- deep learning
- data analysis
- artificial intelligence
- breast cancer risk